Ritonavir Recruiting Phase 2 / 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Severe Acute Respiratory Syndrome Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT04321993Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
NCT04372628Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19
NCT04330690Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial